February 23, 2017 6:04 PM ET

Pharmaceuticals

Company Overview of Cocrystal Pharma, Inc.

Key Executives for Cocrystal Pharma, Inc.

NameBoard RelationshipsTitleAge
Gary L. Wilcox Ph.D.93 RelationshipsCo-Founder, Vice Chairman and Interim Chief Executive Officer69
Sam Lee Ph.D.No RelationshipsCo-Founder and President56
Roger D. Kornberg Ph.D.166 RelationshipsCo-Founder, Chairman of Scientific Advisory Board and Chief Scientist69
Walt Addison Linscott Esq.No RelationshipsGeneral Counsel and Corporate Secretary55
Luz Pascual No RelationshipsVice President of Clinical Development--

Cocrystal Pharma, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Raymond F. Schinazi Ph.D., D.Sc. (Hon.) 65 RelationshipsCocrystal Pharma, Inc.65
Gary L. Wilcox Ph.D. 93 RelationshipsCocrystal Pharma, Inc.69
Roger D. Kornberg Ph.D. 166 RelationshipsCocrystal Pharma, Inc.69
Jane H. Hsiao Ph.D., MBA 60 RelationshipsNon-Invasive Monitoring Systems, Inc.69
Steven D. Rubin J.D., Esq. 100 RelationshipsOpko Health, Inc.56
View All Board Members

Cocrystal Pharma, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee J.D., Esq.Steven D. Rubin100 Relationships3 Executives
Compensation Committee M.D., M.B.A.David S. Block17 Relationships3 Executives
Nominating Committee Ph.D., MBAJane H. Hsiao60 Relationships3 Executives
Corporate Governance Committee Ph.D., MBAJane H. Hsiao60 Relationships3 Executives
Advisory Board Ph.D.Roger D. Kornberg166 Relationships7 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$133.5K
133.5K
345.4K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$133.5K
133.5K
14.9M
Compensation as of Fiscal Year 2015
Cocrystal Pharma, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Heritage Pharmaceuticals Inc. Appoints Scott Delaney as President, with Effect from March 1, 2017
February 22, 2017 7:23 PM ET
ActivX Biosciences, Inc. Announces Management Changes
February 22, 2017 5:00 PM ET
Relief Therapeutics Announces Executive Changes
February 22, 2017 4:31 PM ET
Prevacus, Inc. Announces the Addition of Key Individuals to its Sports Advisory Board
February 22, 2017 3:15 PM ET
Cue Biopharma Strengthens Scientific and Clinical Advisory Board with Leading Oncology and Immunology Experts
February 22, 2017 1:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cocrystal Pharma, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.